https://orcid.org/0000-0002-6772-1633
Citations (5)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Shahrul Mt-Isa, Justin R. Chumbley, Emma L. Crawford, Natalie Banniettis, Ulrike K. Buchwald, Jessica Weaver & Thomas Weiss. (2023) An indirect treatment comparison (ITC) and matching-adjusted indirect comparison (MAIC) between a 15-valent (V114) and a 20-valent (PCV20) pneumococcal conjugate vaccine among healthy infants. Expert Review of Vaccines 22:1, pages 906-917.
Read now
Read now
Kristen Feemster, Natalie Banniettis & Ulrike K. Buchwald. (2022) Letter to the editor in response to: A systematic review of invasive pneumococcal disease vaccine failures and breakthrough with higher-valency pneumococcal conjugate vaccines in children. Expert Review of Vaccines 21:12, pages 1929-1929.
Read now
Read now
Articles from other publishers (3)
Hyunjung Kim, Jigui Yu, Di Bai, Moon H. Nahm & Pengfei Wang. (2022) Potentiating pneumococcal glycoconjugate vaccine PCV13 with saponin adjuvant VSA-1. Frontiers in Immunology 13.
Crossref
Crossref
Naoto Ishimaru, Yohei Kanzawa, Takahiro Nakajima, Kayoko Okamura, Eiichiro Sando, Isao Ito, Saori Kinami & Hisashi Ohnishi. (2022) Specific antibody deficiency to pneumococcal polysaccharide in a young adult with recurrent respiratory infections: a case report. Monaldi Archives for Chest Disease.
Crossref
Crossref
Patricia Izurieta, Mohammad AbdelGhany, Janine Paynter & Helen Petousis-Harris. (2022) Recommendation to Take a Holistic View of the Dynamic Pathogenic Pneumococcal Environment. Clinical Infectious Diseases 75:1, pages e1204-e1205.
Crossref
Crossref